Skip to Content
139

Gilead Sciences

  • Previous Rank116
  • Revenues ($M)$22,127.0
  • Revenue Percent Change-15.2%
  • Profits ($M)$5,455.0
  • Profits Percent Change17.9%
  • Assets ($M)$63,675.0
  • Employees11,000

California-based Gilead is a biopharmaceutical firm best known for its hepatitis C cures Sovaldi and Harvoni.

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Info

CEO
Daniel O'Day
CEO Title
Chairman & Chief Executive Officer
Sector
Health Care
Industry
Pharmaceuticals
HQ Location
Foster City, Calif.
Websitehttp://www.gilead.com
Years on Fortune 500 List11
Employees11,000

Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$22,127.0-15.2%
Profits ($M)$5,455.017.9%
Assets ($M)$63,675.0-
Total Stockholder Equity ($M)$21,387.0-

Profit Ratios

Profit as % of Revenues24.7%
Profits as % of Assets8.6%
Profits as % of Stockholder Equity25.5%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)4.17
EPS % Change (from 2017)18.8%
EPS % Change (5 year annual rate)18.2%
EPS % Change (10 year annual rate)14.8%

Total Return

Total Return to Investors (2018)-9.8%
Total Return to Investors (5 year, annualized)-1.7%
Total Return to Investors (10 year, annualized)10.4%